Ixoreal Biomed highlights an exploratory placebo-controlled study of SRI-81 Shatavari, alone and combined with KSM-66 Ashwagandha, published in the International Journal of Women’s Health.
|Articles|June 1, 2011
EFSA to Assess Risk of Aspartame
Its verdict is scheduled for release next year.
Advertisement
The agency has issued a call for public comment, with a deadline of September 30 of this year.
“This call, running from 1 June to 30 September 2011, has been launched to ensure that EFSA’s risk assessment of the safety of aspartame will be the most thorough and up-to-date yet. To complete its evaluation, EFSA requires all available scientific and technical data – published, unpublished and newly generated – related to the use of aspartame in food and drinks and as a table-top sweetener,” EFSA stated.
Aspartame is a low-calorie, intense sweetener, approximately 200 times sweeter than sugar. European legislation harmonizing its use in foodstuffs was introduced in 1994.
Advertisement
Related to this article
Clinical research moves beyond compliance, focusing on smarter trial design, risk-based quality, and “evidence engineering” to deliver decisive, decision-ready results.
The company says the innovation, built on its CoreNhanced BioJourney platform, is designed for beverage and gummy formats.
AuraFen, BILVORA, and IMBE debut at SupplySide Global 2026, and the company will also highlight its CaFi digestive health ingredient.
Horphag Research's Sébastien Bornet breaks down the clinical science behind Robuvit, exploring how the caffeine-free French oak extract supports mitochondrial energy, mood stability, and stress resilience.
Todd Harrison, co-chair of the FDA practice group at Venable LLP, explains how California’s AB 2779 changes date-labeling requirements for supplements, why stability testing matters, and how companies can navigate evolving state rules while advocating for federal uniformity.
FDA's final NDI guidance sets identity and safety expectations. See what AHPA and CRN say remains unresolved and what it means for suppliers.
The company plans to present Organicaps capsules in size 0, 25 years of UC-II, and liquid-filled capsule technology.
Advertisement
Advertisement
Trending on Nutritional Outlook - Supplement, Food & Beverage Manufacturing Trends
1
Navigating Supplement Ingredients and Claims Regulations in Europe, the US, and Canada
2
CoreFX Launches CreaSHLD-IN Shielded Creatine at SupplySide Global 2026
3
Thirty Years of GCP: The Evolution From Study Execution to Evidence Generation
4
FDA Finalizes NDI Guidance on Identity and Safety Information, Leaving Some Industry Concerns Open
5